A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
Clinical trial NCT00001100 · COMPLETED
Trial details
- NCT number
- NCT00001100
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.